Loss of VRK1 alters the nuclear phosphoproteome in the DNA damage response to doxorubicin
Dynamic chromatin remodeling requires regulatory mechanisms for its adaptation to different nuclear function, which are likely to be mediated by signaling proteins. In this context, VRK1 is a nuclear Ser-Thr kinase that regulates pathways associated with transcription, replication, recombination, an...
| Autores: | , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2024 |
| País: | España |
| Institución: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/364809 |
| Acceso en línea: | http://hdl.handle.net/10261/364809 |
| Access Level: | acceso abierto |
| Palabra clave: | VRK1 Phosphoproteomics Chromatin Nuclear proteins DNA damage DoxorubicinCancer |
| id |
ES_affaeec8645fbd43fa4edae109e35005 |
|---|---|
| oai_identifier_str |
oai:digital.csic.es:10261/364809 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| dc.title.none.fl_str_mv |
Loss of VRK1 alters the nuclear phosphoproteome in the DNA damage response to doxorubicin |
| title |
Loss of VRK1 alters the nuclear phosphoproteome in the DNA damage response to doxorubicin |
| spellingShingle |
Loss of VRK1 alters the nuclear phosphoproteome in the DNA damage response to doxorubicin Navarro Carrasco, Elena VRK1 Phosphoproteomics Chromatin Nuclear proteins DNA damage DoxorubicinCancer |
| title_short |
Loss of VRK1 alters the nuclear phosphoproteome in the DNA damage response to doxorubicin |
| title_full |
Loss of VRK1 alters the nuclear phosphoproteome in the DNA damage response to doxorubicin |
| title_fullStr |
Loss of VRK1 alters the nuclear phosphoproteome in the DNA damage response to doxorubicin |
| title_full_unstemmed |
Loss of VRK1 alters the nuclear phosphoproteome in the DNA damage response to doxorubicin |
| title_sort |
Loss of VRK1 alters the nuclear phosphoproteome in the DNA damage response to doxorubicin |
| dc.creator.none.fl_str_mv |
Navarro Carrasco, Elena Campos Díaz, Aurora Monte-Serrano, Eva Rolfs, Frank Goeij-de Haas, Richard de Pham, Thang V. Piersma, Sander R. Jiménez, Connie R. Lazo, Pedro A. |
| author |
Navarro Carrasco, Elena |
| author_facet |
Navarro Carrasco, Elena Campos Díaz, Aurora Monte-Serrano, Eva Rolfs, Frank Goeij-de Haas, Richard de Pham, Thang V. Piersma, Sander R. Jiménez, Connie R. Lazo, Pedro A. |
| author_role |
author |
| author2 |
Campos Díaz, Aurora Monte-Serrano, Eva Rolfs, Frank Goeij-de Haas, Richard de Pham, Thang V. Piersma, Sander R. Jiménez, Connie R. Lazo, Pedro A. |
| author2_role |
author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Ministerio de Ciencia, Innovación y Universidades (España) Agencia Estatal de Investigación (España) Ministerio de Ciencia e Innovación (España) Junta de Castilla y León European Commission EMBO Ministerio de Universidades (España) Netherlands Organization for Scientific Research Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72] |
| dc.subject.none.fl_str_mv |
VRK1 Phosphoproteomics Chromatin Nuclear proteins DNA damage DoxorubicinCancer |
| topic |
VRK1 Phosphoproteomics Chromatin Nuclear proteins DNA damage DoxorubicinCancer |
| description |
Dynamic chromatin remodeling requires regulatory mechanisms for its adaptation to different nuclear function, which are likely to be mediated by signaling proteins. In this context, VRK1 is a nuclear Ser-Thr kinase that regulates pathways associated with transcription, replication, recombination, and DNA repair. Therefore, VRK1 is a potential regulatory, or coordinator, molecule in these processes. In this work we studied the effect that VRK1 depletion has on the basal nuclear and chromatin phosphoproteome, and their associated pathways. VRK1 depletion caused an alteration in the pattern of the nuclear phosphoproteome, which is mainly associated with nucleoproteins, ribonucleoproteins, RNA splicing and processing. Next, it was determined the changes in proteins associated with DNA damage that was induced by doxorubicin treatment. Doxorubicin alters the nuclear phosphoproteome affecting proteins implicated in DDR, including DSB repair proteins NBN and 53BP1, cellular response to stress and chromatin organization proteins. In VRK1-depleted cells, the effect of doxorubicin on protein phosphorylation was reverted to basal levels. The nuclear phosphoproteome patterns induced by doxorubicin are altered by VRK1 depletion, and is enriched in histone modification proteins and chromatin associated proteins. These results indicate that VRK1 plays a major role in processes requiring chromatin remodeling in its adaptation to different biological contexts. |
| publishDate |
2024 |
| dc.date.none.fl_str_mv |
2024 2024 2024 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 Publisher's version info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10261/364809 |
| url |
http://hdl.handle.net/10261/364809 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
#PLACEHOLDER_PARENT_METADATA_VALUE# #PLACEHOLDER_PARENT_METADATA_VALUE# #PLACEHOLDER_PARENT_METADATA_VALUE# info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2019-105610RB-I00 info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2022-139598OB-I00 info:eu-repo/grantAgreement/AEI//RED2018-102801-T The underlying dataset has been published as supplementary material of the article in the publisher platform at DOI https://doi.org/10.1016/j.cbi.2024.110908 https://doi.org/10.1016/j.cbi.2024.110908 Sí |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Elsevier |
| publisher.none.fl_str_mv |
Elsevier |
| dc.source.none.fl_str_mv |
reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC instname:Consejo Superior de Investigaciones Científicas (CSIC) |
| instname_str |
Consejo Superior de Investigaciones Científicas (CSIC) |
| reponame_str |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| collection |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869416750318092288 |
| spelling |
Loss of VRK1 alters the nuclear phosphoproteome in the DNA damage response to doxorubicinNavarro Carrasco, ElenaCampos Díaz, AuroraMonte-Serrano, EvaRolfs, FrankGoeij-de Haas, Richard dePham, Thang V.Piersma, Sander R.Jiménez, Connie R.Lazo, Pedro A.VRK1PhosphoproteomicsChromatinNuclear proteinsDNA damageDoxorubicinCancerDynamic chromatin remodeling requires regulatory mechanisms for its adaptation to different nuclear function, which are likely to be mediated by signaling proteins. In this context, VRK1 is a nuclear Ser-Thr kinase that regulates pathways associated with transcription, replication, recombination, and DNA repair. Therefore, VRK1 is a potential regulatory, or coordinator, molecule in these processes. In this work we studied the effect that VRK1 depletion has on the basal nuclear and chromatin phosphoproteome, and their associated pathways. VRK1 depletion caused an alteration in the pattern of the nuclear phosphoproteome, which is mainly associated with nucleoproteins, ribonucleoproteins, RNA splicing and processing. Next, it was determined the changes in proteins associated with DNA damage that was induced by doxorubicin treatment. Doxorubicin alters the nuclear phosphoproteome affecting proteins implicated in DDR, including DSB repair proteins NBN and 53BP1, cellular response to stress and chromatin organization proteins. In VRK1-depleted cells, the effect of doxorubicin on protein phosphorylation was reverted to basal levels. The nuclear phosphoproteome patterns induced by doxorubicin are altered by VRK1 depletion, and is enriched in histone modification proteins and chromatin associated proteins. These results indicate that VRK1 plays a major role in processes requiring chromatin remodeling in its adaptation to different biological contexts.This research was funded by grants to P. A. L. from Agencia Estatal de Investigación (https://doi.org/10.13039/501100011033-Ministerio) de Ciencia e Innovación-FEDER “Una manera de hacer Europa” (PID2019-105610RB-I00, PID2022-139598OB-I00, RED2018-102801-T), Consejería de Educación de la Junta de Castilla y León-FEDER (CSI264P20, CLC-2017-01). E. N–C was funded by Agencia Estatal de Investigación-MINECO predoctoral fellowship (BES-2017-080543) and EMBO Scientific Exchange Grant ( 9289). A. C-D was funded by a predoctoral contract from Ministerio de Universidades (FPU20/02978 ). E. M-S. was funded by a predoctoral fellowship (CSI004-18) from Consejería de Educación-Junta de Castilla y León-Fondo Social Europeo. Cancer Center Amsterdam and Netherlands Organization for Scientific Research (NWOMiddelgroot project number 91116017) are acknowledged for support of the mass spectrometry infrastructure and Surfsara for computing infrastructure (reference e-infra180166)”.Peer reviewedElsevierMinisterio de Ciencia, Innovación y Universidades (España)Agencia Estatal de Investigación (España)Ministerio de Ciencia e Innovación (España)Junta de Castilla y LeónEuropean CommissionEMBOMinisterio de Universidades (España)Netherlands Organization for Scientific ResearchConsejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]202420242024info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501Publisher's versioninfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/10261/364809reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Inglés#PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE#info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2019-105610RB-I00info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2022-139598OB-I00info:eu-repo/grantAgreement/AEI//RED2018-102801-TThe underlying dataset has been published as supplementary material of the article in the publisher platform at DOI https://doi.org/10.1016/j.cbi.2024.110908https://doi.org/10.1016/j.cbi.2024.110908Síinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/3648092026-05-22T06:33:51Z |
| score |
15.811543 |